102 related articles for article (PubMed ID: 702944)
21. An analysis of blood pressure effects of nipradilol and prizidilol in normotensive and spontaneously hypertensive rats.
Watanabe TX; Sokabe H; Kawashima K
Jpn J Pharmacol; 1985 Jul; 38(3):273-9. PubMed ID: 3903298
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
[TBL] [Abstract][Full Text] [Related]
23. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
[TBL] [Abstract][Full Text] [Related]
24. A new antihypertensive compound: 3 hydrazino-6- [(2-hydroxypropyl)methylamino] pyridazine dihydrochloride (ISF 2123).
Dorigotti L; Rolandi R; Carpi C
Pharmacol Res Commun; 1976 Jun; 8(3):295-308. PubMed ID: 17122
[No Abstract] [Full Text] [Related]
25. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Baldoli E; Bianchi G; Corsico N; Di Francesco GF
Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
[TBL] [Abstract][Full Text] [Related]
26. Proximal and distal pulse pressure after acute antihypertensive vasodilating drugs in Wistar-Kyoto and spontaneously hypertensive rats.
Tsoucaris D; Benetos A; Legrand M; London GM; Safar ME
J Hypertens; 1995 Feb; 13(2):243-9. PubMed ID: 7615955
[TBL] [Abstract][Full Text] [Related]
27. Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability.
Madeddu P; Anania V; Varoni MV; Parpaglia PP; Demontis MP; Fattaccio MC; Palomba D; Pollock D; Glorioso N
Br J Pharmacol; 1995 Jun; 115(4):557-62. PubMed ID: 7582472
[TBL] [Abstract][Full Text] [Related]
28. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.
Fornes P; Richer C; Vacher E; Bruneval P; Giudicelli JF
J Cardiovasc Pharmacol; 1993 Aug; 22(2):305-13. PubMed ID: 7692174
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats.
Limas C; Westrum B; Limas CJ
Am J Pathol; 1984 Dec; 117(3):360-71. PubMed ID: 6391187
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
Moskowitz RM; Cohn JN
Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
32. Antihypertensive drugs inhibit hypertension-associated aortic DNA synthesis in the rat.
Loeb AL; Bean BL
Hypertension; 1986 Dec; 8(12):1135-42. PubMed ID: 3539794
[TBL] [Abstract][Full Text] [Related]
33. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
Arvola P; Ruskoaho H; Pörsti I
Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
[TBL] [Abstract][Full Text] [Related]
34. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
[TBL] [Abstract][Full Text] [Related]
36. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats.
Dohi Y; Kojima M; Sato K
Hypertension; 1996 Jul; 28(1):58-63. PubMed ID: 8675265
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
[TBL] [Abstract][Full Text] [Related]
38. Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
Barone FC; Coatney RW; Chandra S; Sarkar SK; Nelson AH; Contino LC; Brooks DP; Campbell WG; Ohlstein EH; Willette RN
Cardiovasc Res; 2001 Jun; 50(3):525-37. PubMed ID: 11376628
[TBL] [Abstract][Full Text] [Related]
39. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats.
Teräväinen TL; Mervaala EM; Pörsti I; Laakso J; Vapaatalo H; Karppanen H
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779
[TBL] [Abstract][Full Text] [Related]
40. Hydralazine decreases blood pressure and endothelin-1 mRNA expression in tissues but not cardiac weight in SHR-SP/Izm rats.
Tanabe A; Naruse M; Adachi C; Seki T; Yoshimoto T; Takagi S; Naruse K; Takano K
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S176-8. PubMed ID: 11078370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
